Bg pattern

PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Peyona 20mg/mL solution for infusion and oral solution

caffeine citrate

Read all of this leaflet carefully before your child starts using this medicine because it contains important information for them.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your child's doctor.
  • If your child experiences any side effects, consult your child's doctor, even if they are not listed in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Peyona and what is it used for
  2. What you need to know before your child starts treatment with Peyona
  3. How to use Peyona
  4. Possible side effects
  5. Storage of Peyona
  6. Package contents and further information

1. What is Peyona and what is it used for

Peyona contains the active substance caffeine citrate, which is a central nervous system stimulant belonging to a group of medicines called methylxanthines.

Peyona is used to treat apnea of prematurity (primary apnea of premature infants).

These brief periods during which premature infants stop breathing are due to the fact that the child's respiratory center is not fully developed.

It has been observed that this medicine reduces the number of apnea episodes in premature infants.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before your child starts treatment with Peyona

Do not use Peyona

  • if your newborn is allergic to caffeine citrate or any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your child's doctor before starting treatment with Peyona.

Before starting treatment for apnea of prematurity with Peyona, your child's doctor should have ruled out or adequately treated other causes of apnea.

Peyona should be used with caution. Inform your child's doctor:

  • if your child has a history of seizures
  • if your child has heart disease
  • if your child has kidney or liver problems
  • if your child has frequent regurgitation
  • if your child produces more urine than normal
  • if your child does not show sufficient weight gain or does not eat enough
  • if you (the mother) consumed caffeine before childbirth

Other medicines and Peyona

Tell your child's doctor if they are taking, have recently taken, or might take any other medicines.

Tell your child's doctor if they have been previously treated with theophylline.

Do not use the following medicines during treatment with Peyona without talking to your child's doctor first. The doctor may need to adjust the dose or change one of the medicines:

  • theophylline (used to treat respiratory difficulties)
  • doxapram (used to treat respiratory difficulties)
  • cimetidine (used to treat stomach diseases)
  • ketoconazole (used to treat fungal infections)
  • phenobarbital (used to treat epilepsy)
  • phenytoin (used to treat epilepsy)

This medicine may increase the risk of severe intestinal disease with bloody stools (necrotizing enterocolitis) when administered with certain medications used to treat stomach diseases (such as H2 receptor antagonists or proton pump inhibitors that reduce gastric acid secretion).

Pregnancy and breastfeeding

If you (the mother) are breastfeeding while your child is being treated with Peyona, you should not drink coffee or take other products with high caffeine content, as caffeine passes into breast milk.

Peyona contains sodium

This medicine contains less than 1 mmol (23 mg) of sodium per dose; it is essentially "sodium-free".

3. How to use Peyona

Peyona should only be used in a neonatal intensive care unit with adequate facilities for patient observation and monitoring. Treatment should be initiated under the supervision of a doctor with experience in neonatal intensive care.

Dose

Your child's doctor will prescribe the correct amount of Peyona based on your child's weight.

The initial dose is 20 mg per kg of body weight (equivalent to 1 mL per kg of body weight).

The maintenance dose is 5 mg per kg of body weight (equivalent to 0.25 mL per kg of body weight) every 24 hours.

Route and method of administration

Peyona should be administered by controlled intravenous infusion using a infusion pump with syringe or other volumetric infusion device. This method is also known as "drip".

Some doses (maintenance doses) may be administered orally.

It may be necessary for your child's doctor to monitor caffeine concentrations through periodic blood tests throughout treatment to avoid toxicity.

Duration of treatment

Your child's doctor will decide exactly how long your child should be treated with Peyona. If your child remains apnea-free for 5 to 7 days, the doctor will discontinue treatment.

If your child receives more Peyona than they should

Your child may experience fever, rapid breathing (tachypnea), nervousness, muscle tremors, vomiting, elevated blood sugar (hyperglycemia), low potassium levels (hypokalemia), elevated blood levels of certain chemicals (urea), and increased white blood cell count (leukocytosis) and seizures if they receive more caffeine citrate than they should.

In these cases, treatment with Peyona should be discontinued immediately and your child's doctor will need to treat the overdose.

If you have any further questions about the use of this medicine, ask your child's doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. However, it is difficult to distinguish them from the frequent complications that occur in premature infants and from the complications of the disease itself.

Your child may experience some of the following reactions during treatment with Peyona:

Serious side effects

Side effectswhose frequency cannot be estimated from the available data.

  • severe intestinal disease with bloody stools (necrotizing enterocolitis).

The following other side effects may also be considered serious by your child's doctor in the context of the overall clinical assessment.

Other side effects

Side effects observed frequently(may affect up to 1 in 10 people)

  • local inflammatory reactions at the infusion site
  • heart disorders such as rapid heart rate (tachycardia)
  • changes in blood sugar or serum levels (hyperglycemia)

Side effects observed infrequently(may affect up to 1 in 100 people)

  • central nervous system stimulation, such as seizures
  • heart disorders such as irregular heart rhythm (arrhythmia)

Side effects observed rarely(may affect up to 1 in 1,000 people)

  • allergic reactions

Side effectswhose frequency cannot be estimated from the available data:

  • blood infection (sepsis)
  • changes in blood sugar or serum levels (hypoglycemia), growth delay, feeding intolerance
  • central nervous system stimulation, such as irritability, nervousness, and restlessness; brain injury
  • hearing loss
  • regurgitation, increased aspiration of stomach contents
  • increased urine output, increased levels of certain components in the urine (sodium and calcium)
  • changes in blood tests (reduced hemoglobin after prolonged treatment and decreased thyroid hormone at the start of treatment)

Reporting of side effects

If your newborn experiences any side effects, consult your doctor, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's online reporting system: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Peyona

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions.

All parenteral solution ampoules should be inspected visually for particulate matter and discoloration prior to administration. Once the ampoule is opened, the medicine should be used immediately.

6. Package contents and further information

Composition of Peyona

The active substance is caffeine citrate.

Each mL contains 20 mg of caffeine citrate (equivalent to 10 mg/mL of caffeine base).

Each 1 mL ampoule contains 20 mg of caffeine citrate (equivalent to 10 mg of caffeine base).

Each 3 mL ampoule contains 60 mg of caffeine citrate (equivalent to 30 mg of caffeine base).

The other ingredients are citric acid, sodium citrate, and water for injections.

Appearance and package contents

Peyona is a solution for infusion and oral solution.

Peyona is a clear and colorless solution presented in glass ampoules. Each carton contains 10 ampoules.

Marketing authorisation holder

Chiesi Farmaceutici S.p.A.

Via Palermo 26/A

43122 Parma

Italy

Manufacturer (batch release)

Alfasigma S.p.A.

Via Enrico Fermi 1

Alanno (PE)

Italy

Chiesi Pharmaceuticals GmbH,

Gonzagagasse 16/16,

A-1010 Wien

Austria

You can obtain further information on this medicine by contacting the local representative of the marketing authorisation holder:

Spain

Chiesi España, S.A.U.

Tel: + 34 93 494 8000

Date of last revision of this leaflet: December 2021

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

-------------------------------------------------------------------------------------------------------------------------

This information is intended for healthcare professionals only:

If you require detailed information, consult the Summary of Product Characteristics (SPC) for PEYONA attached.

Online doctors for PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION

Discuss questions about PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
0.0 (1)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations.

In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life.

Patients consult Dr Daria Portnova for the following concerns:

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.
Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.
Camera Book a video appointment
€110
5.0 (77)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€89
5.0 (137)
Doctor

Taisiia Proida

Psychiatry 7 years exp.

Dr. Taisiia Proida is a psychiatrist and cognitive behavioural therapist (CBT), and a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care.

She specialises in consultations and ongoing support for a wide range of mental health concerns, including:

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders.

She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Camera Book a video appointment
€120

Frequently Asked Questions

Is a prescription required for PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION?
PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION?
The active ingredient in PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION is caffeine. This information helps identify medicines with the same composition but different brand names.
Who manufactures PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION?
PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION is manufactured by Chiesi Farmaceutici S.P.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to PEYONA 20 mg/ml SOLUTION FOR INFUSION AND ORAL SOLUTION?
Other medicines with the same active substance (caffeine) include DURVITAN 300 mg PROLONGED-RELEASE HARD CAPSULES, GENCEBOK 10 mg/ml SOLUTION FOR INFUSION, ATAMAX 10 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media